SEBI has issued a circular introducing a framework for monitoring and supervising system audits of stock brokers (SBs) through technology-based measures, effective for FY 2025-26. The framework aims ...
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...